Merck & Co Inc (NYSE:MRK)

81.17
Delayed Data
As of May 24
 +0.15 / +0.19%
Today’s Change
58.03
Today|||52-Week Range
83.85
+6.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$208.6B

Company Description

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Contact Information

Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth New Jersey 07033
P:(908) 740-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders42.82%
Other institutional34.97%
Individual stakeholders0.12%

Top Executives

Kenneth C. FrazierChairman, President & Chief Executive Officer
Robert M. DavisCFO & Executive Vice President-Global Services
Sandy TrempsVice President-R&D IT CIO
James H. ScholefieldChief Information & Digital Officer
Richard R. DeLucaExecutive Vice President & President-Animal Health